Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Mar 4, 2009

Premium

Navigenics announced last week that Mari Baker, president and CEO of the company since its inception in 2007, would step down from her post to pursue other opportunities.

The company's board of directors "is actively interviewing candidates for the president and CEO position," Navigenics said in a statement. In the meantime, board members Dana Mead and Sue Siegel will work together with the existing executive team to lead the company.

Baker's departure occurred this week. She will continue to serve as a board.


Illumina CEO Jay Flatley has joined the board of directors of Helixis, a developer of nucleic acid analysis tools. Prior to joining Illumina, Flatley was president and CEO of Molecular Dynamics, now part of GE Healthcare, and led that company's initial public offering in 1993.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.